BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Doxorubicin
,
rs2230926
,
GATA1
,
Metabolism of xenobiotics
,
Breast Cancer
,
Hypothalamus
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
shRNA
Summary
General Info
Curated Studies
Most Correlated Studies
Dermal fibroblasts with UPF1 shRNA or RBPJ shRNA knockdown
HeLa cell lines transfected with PHF8 shRNA or control shRNA
Ovarian cancer OVCAR-5 cells with YAP1 shRNA or PKCI shRNA knockdown
Colo16 cells with hnRNP- silencing by shRNA
HUVECs with SIN3A shRNA cultured in hypoxia
Explore Curated Studies Results
Literature
Most Relevant Literature
Design of antiviral AGO2-dependent short hairpin RNAs.
Activation of PKR by a short-hairpin RNA.
Activation of PKR by a short-hairpin RNA.
Uncovering hidden cancer self-dependencies through analysis of shRNA-level dependency scores.
Preparation and Use of shRNA for Knocking Down Specific Genes.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
An Efficacy and Safety Study of shRNA-modified CD34+ Cells in HIV-infected Patients.
Phase I Intratumoral Pbi-shRNA STMN1 LP in Advanced and/or Metastatic Cancer
Trial of Bi-shRNA-furin and Granulocyte Macrophage Colony Stimulating Factor (GMCSF) Augmented Autol…
Treatment of Chronic Lymphocytic Leukemia
Pbi-shRNAâ„¢ EWS/FLI1 Type 1 LPX in Subjects With Advanced Ewing's Sarcoma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ